Medical Weight Loss for Danbury, Connecticut Residents

Danbury, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Danbury through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Skip the commute, keep the care: from Downtown and the greater western Connecticut area and anywhere else in Danbury, you meet your physician on a video call from home or work. We confirm telehealth eligibility during the consultation. Doctor review just $119 (medication separate).

Why Danbury Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Danbury a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Connecticut. That is the entire promise, and we keep it.

Medical weight loss for Danbury is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Think of our Costa Mesa clinic as your weight-loss provider even though you live in Danbury, because telehealth delivers the same physician-led program to Connecticut without asking you to leave home. We care for patients throughout Downtown and the greater western Connecticut area. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Danbury or out toward Downtown and the greater western Connecticut area.

Most people across Danbury do not wait for an opening, they pick a time, meet Dr. Sharma by video, and can begin treatment within days. Because every Danbury visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. New Hope Weight Loss serves patients throughout Connecticut by secure telehealth from our Costa Mesa, California clinic, bringing physician-supervised GLP-1 programs to your door without an office visit.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Danbury telehealth visits.

How Telehealth Works for Danbury

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Danbury address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Danbury

How does someone in Danbury access New Hope Weight Loss?

Access from Danbury is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Danbury, Connecticut through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Danbury residents?

A clinic visit is never part of it for Danbury. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Danbury inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Danbury patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Danbury residents are charged no distance surcharge.

What areas of Danbury do you serve?

We serve patients from across Danbury by telehealth, including Downtown and the greater western Connecticut area.

How is medication shipped to Danbury patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Danbury address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Danbury Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Danbury, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.